sumatriptan has been researched along with Vestibular Diseases in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, SY | 1 |
| Seo, MW | 1 |
| Kim, YH | 1 |
| Choi, KD | 1 |
| Kim, DS | 1 |
| Shin, BS | 1 |
1 other study available for sumatriptan and Vestibular Diseases
| Article | Year |
|---|---|
Gaze-evoked and rebound nystagmus in a case of migrainous vertigo.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Migraine Disorders; | 2009 |